Medical Cannabis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Medical Cannabis stocks.

Medical Cannabis Stocks Recent News

Date Stock Title
May 16 TLRY Cannabis stocks rally after DOJ proposal to reclassify marijuana
May 16 CGC Pot Stocks Surge as Biden ‘Reschedules’ Marijuana
May 16 TLRY Pot Stocks Surge as Biden ‘Reschedules’ Marijuana
May 16 AKAN Akanda Corp. Receives Notice of Non-Compliance from NASDAQ
May 16 MJ Cannabis stocks rally as DOJ proposes reclassifying marijuana
May 16 CGC Biden administration reportedly moves to reclassify marijuana (update)
May 16 CGC Canopy Growth to Report Fourth Quarter and Fiscal Year 2024 Financial Results on May 30, 2024
May 16 TLRY SweetWater Brewing Launches New Sunset Sippin’ Cocktail Inspired Hard Seltzers
May 16 VFF Introducing Kush God: the next big strain from Pure Sunfarms
May 15 ACB Aurora Cannabis Announces Appointment of New Director
May 14 OGI Organigram (OGI) Q2 2024 Earnings Call Transcript
May 14 TLRY Cannabis Stock Gainers And Losers From May 14, 2024
May 14 ACB Cannabis Stock Gainers And Losers From May 14, 2024
May 14 TLRY Why Aurora Cannabis, Tilray Brands, and SNDL Inc. Stocks Lit Up on Tuesday
May 14 ACB Why Aurora Cannabis, Tilray Brands, and SNDL Inc. Stocks Lit Up on Tuesday
May 14 OGI Organigram Holdings Inc. (OGI) Q2 2024 Earnings Call Transcript
May 14 TLRY Tilray to issue 13.1M shares in debt-for-equity deal
May 14 OGI Organigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International Markets
May 14 TLRY Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd
May 14 OGI Organigram Holdings reports Q2 results
Medical Cannabis

Medical cannabis, or medical marijuana, is cannabis and cannabinoids that are recommended by doctors for their patients. The use of cannabis as medicine has not been rigorously tested due to production restrictions and other governmental regulations. Limited evidence suggests that cannabis can reduce nausea and vomiting during chemotherapy, improve appetite in people with HIV/AIDS, and reduce chronic pain and muscle spasms.Short-term use increases the risk of minor and major adverse effects. Common side effects include dizziness, feeling tired, vomiting, and hallucinations. Long-term effects of cannabis are not clear. Concerns include memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.The Cannabis plant has a history of medicinal use dating back thousands of years in many cultures. A number of medical organizations have requested removal of cannabis from the list of Schedule I controlled substances, followed by regulatory and scientific review. Others oppose its legalization, such as the American Academy of Pediatrics.Medical cannabis can be administered through a variety of methods, including capsules, lozenges, tinctures, dermal patches, oral or dermal sprays, cannabis edibles, and vaporizing or smoking dried buds. Synthetic cannabinoids are available for prescription use in some countries, such as dronabinol and nabilone. Countries that allow the medical use of whole-plant cannabis include Australia, Canada, Chile, Colombia, Germany, Greece, Israel, Italy, the Netherlands, Peru, Poland, Portugal, and Uruguay. In the United States, 33 states and the District of Columbia have legalized cannabis for medical purposes, beginning with the passage of California's Proposition 215 in 1996. Although cannabis remains prohibited for any use at the federal level, the Rohrabacher–Farr amendment was enacted in December 2014, limiting the ability of federal law to be enforced in states where medical cannabis has been legalized.

Browse All Tags